Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa

• Päätekijät: Kevin T. Savage, BA (Tekijä), Elena Gonzalez Brant, MD (Tekijä), Monica Rosales Santillan, MD (Tekijä), Peyton C. Morss, BA (Tekijä), Prerna Salian, MPH (Tekijä), Kelsey S. Flood, MD (Tekijä), Martina L. Porter, MD (Tekijä), Alexa B. Kimball, MD, MPH (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wolters Kluwer, 2020-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Methotrexate is an immunomodulatory therapy that may offer benefit to patients with hidradenitis suppurativa (HS). Despite its theoretical advantages, there is a paucity of available data regarding long-term methotrexate use in patients with HS. Objective: This study aimed to assess whet...